Atlas Trials

Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients

Clinical trial NCT03921684 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03921684
Sponsor
Baruch Brenner
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2019-04-10
Primary completion
2024-10-28
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.